rfhg_157645.1

Basic information about the TSS

---

TSS ID: rfhg_157645.1 TSS ID(Version3): hg_128528.1 hg_128529.1 Species: human Chr: chr12		Start: 122752815 End: 122752894 Strand: +
Source datasets	FANTOM5|DBTSS|DRA000914|ENCODE|PRJDB5282|PRJNA4843412 |DRA013844|PRJNA401781|PRJNA548673|PRJNA597322|PRJNA615891
Protocol	CAGE|TSS-seq|C1CAGE|NETCAGE|oligo_capping|ReCappable-seq |RAMPAGE|STRIPE-seq|SLIC_CAGE|TIF-seq2
TSS cluster detected*	15

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2617688,EH38E1651805)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000455982.2:0 ENST00000280557.11:0 ENST00000539463.1:0 ENST00000537955.1:0 AF038554:0 AK299463:0 AB014731:0 BC007860:0 GeneID: 8562 HGNC/MGI_ID: HGNC:2769 UniProt_ID: A0A024RBR3 F8VVL1 Nearer transcript ids and distances: BC000925:27

Gene_name: density regulated re-initiation and release factor Gene_symbol: DENR Gene_synonyms: DRP DRP1 SMAP-3 Gene_source: HGNC:2769

TATA-Box annotation

---

Distance to TSS:	30
Nearest PromoterID:	NM_003677
Entrez ID:	8562
Nearest Unigene:	Hs.22393
Nearest Refseq:	NM_003677
Nearest Ensembl:	ENSG00000139726
Gene Name:	density regulated re-initiation and release factor
Gene Alias:	DRP|DRP1|SMAP-3
Gene Type:	protein-coding
CpG%:	0.126582
GC%:	0.712500
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@DENR p2@DENR p3@DENR
Sample		p1@DENR	p2@DENR	p3@DENR
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	75.00	49.48	2.14
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	74.45	51.39	1.42
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	80.83	49.00	1.93
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	58.42	49.90	1.46
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	62.09	49.04	0.90
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	61.44	45.16	1.36
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	86.72	54.69	1.96
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	69.76	45.30	0.97
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	93.82	45.52	0.85
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	65.50	51.01	1.16
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	75.19	45.68	0.81
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	61.39	57.73	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	52.55	6.45	1.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	45.41	6.92	1.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	56.43	9.00	0.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	37.47	8.30	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	33.85	3.49	0.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	41.34	5.48	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	32.52	8.00	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	54.46	7.37	1.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	53.59	9.09	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	52.48	7.08	1.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	41.62	6.33	1.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	41.01	7.52	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	46.44	9.03	1.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	39.88	8.86	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	37.36	6.04	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	49.74	7.07	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	47.97	6.30	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	59.18	7.78	1.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	40.82	6.91	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	48.26	6.64	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	44.53	5.91	1.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	41.56	7.59	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	47.12	5.98	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	50.01	6.52	1.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	53.14	6.74	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	44.93	4.63	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	55.91	7.83	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	47.29	4.08	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	40.70	6.59	1.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	41.72	7.17	0.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	52.51	6.96	1.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	45.11	7.17	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	55.81	8.03	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	50.02	6.05	0.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	47.74	5.04	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	47.09	5.96	1.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	46.68	8.38	1.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	43.88	6.67	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	41.40	5.94	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	56.04	8.23	1.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	195.89	69.96	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	32.65	6.03	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	38.44	7.95	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	62.08	11.75	3.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	49.14	5.51	0.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	42.46	9.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	36.61	6.42	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	66.95	9.43	1.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	31.73	7.05	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	37.01	3.36	1.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	50.95	12.74	4.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	53.34	6.80	1.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	45.81	9.42	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	37.98	5.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	290.95	48.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	157.95	31.59	7.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	27.30	1.46	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	43.14	3.97	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	44.10	4.22	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	43.72	4.64	1.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	33.72	4.02	0.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	38.22	1.83	0.31
Adipocyte - breast, donor1	11376-118A8	34.37	5.54	1.58
Adipocyte - breast, donor2	11327-117E4	35.61	3.05	0.16
Adipocyte - omental, donor1	11473-119C6	32.06	6.23	1.27
Adipocyte - omental, donor2	11474-119C7	33.64	5.23	0.00
Adipocyte - omental, donor3	11475-119C8	40.53	4.02	0.67
Adipocyte - perirenal, donor1	11476-119C9	33.18	3.83	1.28
Adipocyte - subcutaneous, donor1	11259-116F8	14.29	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	35.68	4.97	2.26
Adipocyte - subcutaneous, donor3	11408-118E4	20.68	2.26	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	61.41	5.67	0.78
Adipocyte differentiation, day04, donor2	13022-139D7	47.10	3.35	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	47.39	3.90	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	55.84	7.64	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	87.43	12.23	2.33
Adipocyte differentiation, day08, donor2	13023-139D8	50.35	5.16	1.29
Adipocyte differentiation, day08, donor3	13026-139E2	36.26	3.20	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	60.10	9.46	1.11
Adipocyte differentiation, day12, donor1	13021-139D6	59.06	7.90	1.25
Adipocyte differentiation, day12, donor2	13024-139D9	32.40	3.77	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	41.56	5.56	0.65
Adipocyte differentiation, day12, donor4	13030-139E6	53.59	8.83	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	38.01	8.40	0.44
Alveolar Epithelial Cells, donor2	11590-120G6	12.19	4.66	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	7.19	4.79	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	40.66	10.79	1.62
Amniotic Epithelial Cells, donor2	11613-122A2	21.76	5.02	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	26.50	5.55	0.82
Anulus Pulposus Cell, donor1	11248-116E6	56.30	8.70	2.29
Anulus Pulposus Cell, donor2	11463-119B5	60.98	6.37	2.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	39.09	8.09	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	51.66	7.81	0.87
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	34.24	6.42	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	49.02	4.48	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	41.73	8.85	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	29.70	4.62	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	34.44	4.55	1.30
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	47.09	4.37	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	21.97	2.38	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	44.07	6.03	1.88
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	39.91	4.35	1.45
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	33.85	5.02	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	42.67	6.10	0.82
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	43.67	5.46	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	39.21	4.37	0.30
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	43.40	8.04	1.07
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	43.83	5.48	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	31.27	5.08	0.53
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	38.04	7.80	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	45.78	4.64	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	15.61	3.60	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	56.64	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	39.28	4.80	0.69
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	12.58	4.19	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	31.55	4.85	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	42.12	5.69	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	30.28	2.42	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	42.75	5.70	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	50.24	5.13	1.07
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	29.42	4.65	0.52
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	39.41	3.75	0.94
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	32.15	2.25	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	34.25	2.85	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	41.53	8.77	1.17
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	49.07	8.13	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	38.02	9.50	3.56
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	44.75	3.56	2.03
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	43.04	6.37	0.76
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	26.05	1.91	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	47.04	9.93	1.73
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	45.30	6.14	1.48
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	25.23	3.48	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	32.12	5.67	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	49.67	5.59	0.85
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	25.48	2.32	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	52.81	12.68	2.11
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	46.74	4.72	0.86
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	30.08	3.01	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	38.64	0.73	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	45.52	6.21	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	20.40	7.65	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	31.78	7.63	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	45.21	7.23	1.24
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	31.82	5.51	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	47.32	6.21	0.96
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	42.80	4.43	1.11
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	24.41	4.58	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	43.20	3.88	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	49.78	8.47	0.79
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	30.17	2.91	0.73
Astrocyte - cerebellum, donor1	11500-119F6	47.16	8.23	0.49
Astrocyte - cerebellum, donor2	11580-120F5	43.99	2.91	0.34
Astrocyte - cerebellum, donor3	11661-122F5	21.60	2.52	0.42
Astrocyte - cerebral cortex, donor1	11235-116D2	64.84	7.67	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	90.92	13.27	0.81
Astrocyte - cerebral cortex, donor3	11392-118C6	85.17	10.74	0.89
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	115.60	16.97	3.21
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	130.92	21.55	3.38
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	123.81	19.69	4.44
Basophils, donor1	12241-129G9	35.05	8.89	2.88
Basophils, donor2	12242-129H1	57.37	6.49	3.25
Basophils, donor3	12243-129H2	47.19	3.97	1.18
Bronchial Epithelial Cell, donor1	11511-119G8	16.82	4.10	0.65
Bronchial Epithelial Cell, donor2	11591-120G7	14.63	1.83	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	28.69	7.17	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	47.07	5.65	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	29.74	5.41	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	32.93	4.84	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	43.19	9.18	0.36
Burkitt's lymphoma cell line:DAUDI	10422-106C8	67.91	28.34	2.06
Burkitt's lymphoma cell line:RAJI	10476-106I8	106.44	29.35	2.33
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	86.66	16.63	3.20
CD133+ stem cells - cord blood derived, pool1	12223-129E9	186.15	10.34	20.68
CD14+ Monocytes, donor1	11224-116B9	51.28	2.82	1.13
CD14+ Monocytes, donor2	11305-117B9	48.63	2.60	0.74
CD14+ Monocytes, donor3	11381-118B4	49.40	5.05	1.10
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	43.31	0.57	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	49.28	0.76	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	55.56	0.99	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	31.22	4.34	0.87
CD14+ monocytes - mock treated, donor2	11873-125C1	26.86	4.53	1.21
CD14+ monocytes - mock treated, donor3	11883-125D2	38.85	4.97	0.95
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	17.41	4.02	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	18.77	5.80	1.10
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	26.53	4.21	2.23
CD14+ monocytes - treated with BCG, donor1	11860-125A6	21.54	5.29	1.17
CD14+ monocytes - treated with BCG, donor2	11870-125B7	22.61	8.55	1.42
CD14+ monocytes - treated with BCG, donor3	11880-125C8	40.48	8.92	3.92
CD14+ monocytes - treated with Candida, donor1	11868-125B5	13.81	3.75	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	32.74	8.98	1.06
CD14+ monocytes - treated with Candida, donor3	11888-125D7	32.17	6.66	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	19.34	3.12	0.45
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	27.14	3.99	2.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	24.98	3.75	1.25
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	17.85	2.52	0.92
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	22.39	4.52	1.81
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	22.26	3.06	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	18.29	2.96	0.54
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	23.73	4.88	2.09
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	29.04	5.47	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	13.59	2.57	0.55
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	16.20	4.58	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	26.32	2.63	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	22.15	13.78	1.39
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	34.94	10.78	3.35
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	50.44	17.24	7.33
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	18.43	3.28	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	14.14	2.78	1.39
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	20.65	3.48	0.46
CD14+CD16+ Monocytes, donor1	11789-124B7	51.00	3.05	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	42.73	2.08	0.92
CD14+CD16+ Monocytes, donor3	11912-125G4	49.61	4.77	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	44.07	2.65	0.93
CD14+CD16- Monocytes, donor2	11799-124C8	42.44	2.97	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	69.12	3.79	0.67
CD14-CD16+ Monocytes, donor1	11790-124B8	43.89	3.06	0.51
CD14-CD16+ Monocytes, donor2	11800-124C9	48.52	2.85	0.44
CD14-CD16+ Monocytes, donor3	11911-125G3	61.90	5.47	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	81.29	0.00	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	84.75	4.07	2.71
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	99.42	8.28	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	76.22	8.00	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	130.80	2.68	1.61
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	97.57	7.72	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	95.69	4.71	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	121.28	2.64	1.32
CD19+ B Cells, donor1	11544-120B5	69.86	7.40	1.64
CD19+ B Cells, donor2	11624-122B4	49.33	3.63	0.73
CD19+ B Cells, donor3	11705-123B4	57.05	6.06	1.51
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	57.38	17.37	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	41.55	12.78	0.00
CD34+ Progenitors, donor1	11545-120B6	52.21	12.05	7.03
CD34+ Progenitors, donor2	11625-122B5	75.84	6.18	5.06
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	85.30	14.28	1.50
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	91.77	12.85	2.93
CD4+ T Cells, donor1	11225-116C1	101.76	10.00	2.50
CD4+ T Cells, donor2	11306-117C1	76.55	6.74	1.84
CD4+ T Cells, donor3	11382-118B5	71.37	7.32	1.52
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	76.57	5.62	7.91
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	71.87	6.51	4.04
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	62.09	4.31	6.04
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	77.75	7.59	1.90
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	89.19	5.62	2.11
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	79.11	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	69.66	6.65	2.89
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	68.46	4.41	4.74
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	63.19	5.64	3.55
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	69.93	5.83	3.14
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	86.30	4.54	2.45
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	76.56	7.04	3.08
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	64.93	6.32	2.95
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	66.90	7.27	2.49
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	55.80	8.69	3.01
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	74.24	2.99	2.45
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	100.76	5.90	1.61
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	82.49	10.76	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	72.32	7.23	3.15
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	55.89	8.45	3.03
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	70.61	6.94	3.99
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	72.30	6.07	1.52
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	69.32	3.90	1.73
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	98.93	7.41	4.79
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	127.18	3.96	2.97
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	112.63	3.69	2.77
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	120.04	9.77	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	141.23	9.14	1.94
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	161.22	4.91	1.72
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	83.16	0.00	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	112.09	6.09	3.22
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	150.96	6.92	2.77
CD8+ T Cells, donor1	11226-116C2	72.68	9.82	3.27
CD8+ T Cells, donor2	11307-117C2	66.83	7.13	3.00
CD8+ T Cells, donor3	11383-118B6	95.44	7.83	3.03
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	48.86	10.78	2.52
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	40.74	5.27	0.72
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	30.64	9.03	1.92
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	42.93	7.81	1.50
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	44.16	8.16	1.92
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	39.79	8.64	2.50
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	52.58	8.91	1.52
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	43.43	8.95	2.63
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	43.15	10.08	2.58
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	43.77	12.68	2.42
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	41.25	12.49	1.16
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	53.82	8.26	4.53
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	35.02	3.50	3.06
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	32.79	7.29	2.28
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	30.58	5.97	2.24
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	39.26	6.48	1.44
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	48.34	8.34	1.73
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	43.37	6.36	2.83
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	47.22	12.68	2.22
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	47.67	8.00	2.46
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	53.22	6.41	2.89
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	52.02	9.56	2.29
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	42.17	8.28	1.18
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	32.53	3.78	2.27
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	55.40	8.03	2.41
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	46.16	6.29	1.40
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	61.11	11.02	3.01
Cardiac Myocyte, donor1	11525-119I4	65.80	10.97	7.31
Cardiac Myocyte, donor2	11605-120I3	47.43	6.42	1.98
Cardiac Myocyte, donor3	11686-122I3	58.30	6.10	0.32
Chondrocyte - de diff, donor1	11261-116G1	72.80	7.63	1.39
Chondrocyte - de diff, donor2	11338-117F6	23.10	3.91	0.00
Chondrocyte - de diff, donor3	11410-118E6	40.96	4.66	0.23
Chondrocyte - re diff, donor2	11339-117F7	79.68	7.16	0.90
Chondrocyte - re diff, donor3	11411-118E7	33.57	3.24	1.21
Ciliary Epithelial Cells, donor1	11242-116D9	92.27	13.43	1.38
Ciliary Epithelial Cells, donor2	11323-117D9	69.05	15.82	1.50
Ciliary Epithelial Cells, donor3	11399-118D4	81.15	12.12	1.42
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	41.72	4.49	0.46
Corneal Epithelial Cells, donor1	11526-119I5	14.93	2.63	0.00
Corneal Epithelial Cells, donor2	11606-120I4	21.61	5.69	0.00
Corneal Epithelial Cells, donor3	11687-122I4	24.54	4.86	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	32.19	1.65	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	34.70	0.32	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	24.15	3.45	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	32.83	1.30	0.22
Dendritic Cells - plasmacytoid, donor1	11228-116C4	66.28	9.22	1.02
Dendritic Cells - plasmacytoid, donor2	11309-117C4	76.39	7.83	1.31
Dendritic Cells - plasmacytoid, donor3	11385-118B8	96.30	7.26	1.94
Endothelial Cells - Aortic, donor0	11207-116A1	34.02	5.00	0.33
Endothelial Cells - Aortic, donor1	11263-116G3	29.93	4.69	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	33.09	4.81	0.85
Endothelial Cells - Aortic, donor3	11412-118E8	38.93	5.11	0.00
Endothelial Cells - Artery, donor1	11264-116G4	42.18	7.56	0.58
Endothelial Cells - Artery, donor2	11341-117F9	60.70	10.59	1.88
Endothelial Cells - Artery, donor3	11413-118E9	40.50	7.89	1.58
Endothelial Cells - Lymphatic, donor1	11236-116D3	39.45	5.54	1.55
Endothelial Cells - Lymphatic, donor2	11317-117D3	58.42	8.52	1.52
Endothelial Cells - Lymphatic, donor3	11393-118C7	46.23	5.64	1.41
Endothelial Cells - Microvascular, donor1	11265-116G5	33.87	4.46	1.49
Endothelial Cells - Microvascular, donor2	11342-117G1	30.72	3.12	2.60
Endothelial Cells - Microvascular, donor3	11414-118F1	26.37	1.99	0.57
Endothelial Cells - Thoracic, donor1	11266-116G6	88.03	18.41	2.00
Endothelial Cells - Thoracic, donor2	11343-117G2	29.35	3.67	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	97.04	15.90	1.62
Endothelial Cells - Umbilical vein, donor2	11324-117E1	94.07	14.77	1.52
Endothelial Cells - Umbilical vein, donor3	11400-118D5	108.08	14.66	1.47
Endothelial Cells - Vein, donor1	11267-116G7	28.44	9.10	1.14
Endothelial Cells - Vein, donor2	11344-117G3	32.83	2.79	0.00
Endothelial Cells - Vein, donor3	11416-118F3	46.95	7.54	0.47
Eosinophils, donor1	12244-129H3	91.48	0.00	0.00
Eosinophils, donor2	12245-129H4	34.66	1.65	0.00
Eosinophils, donor3	12246-129H5	32.10	3.57	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	16.86	4.15	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	22.88	2.08	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	51.72	6.57	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	24.63	3.83	0.22
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	48.54	6.18	1.19
Fibroblast - Aortic Adventitial, donor1	11245-116E3	51.54	10.43	0.73
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	32.34	5.19	2.73
Fibroblast - Aortic Adventitial, donor2	11326-117E3	45.35	7.07	0.84
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	26.35	5.53	2.11
Fibroblast - Aortic Adventitial, donor3	11401-118D6	65.44	9.97	0.66
Fibroblast - Cardiac, donor1	11268-116G8	48.08	5.90	0.00
Fibroblast - Cardiac, donor2	11345-117G4	28.04	2.27	0.00
Fibroblast - Cardiac, donor3	11417-118F4	29.49	4.73	0.63
Fibroblast - Cardiac, donor4	11452-119A3	66.99	11.21	2.12
Fibroblast - Cardiac, donor5	11456-119A7	68.78	9.14	0.63
Fibroblast - Cardiac, donor6	11460-119B2	64.73	7.28	0.30
Fibroblast - Choroid Plexus, donor1	11492-119E7	37.92	4.15	0.94
Fibroblast - Choroid Plexus, donor2	11572-120E6	46.16	3.45	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	43.94	16.11	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	54.66	8.30	1.61
Fibroblast - Conjunctival, donor3	11692-122I9	48.51	3.39	1.87
Fibroblast - Dermal, donor1	11269-116G9	57.29	6.57	3.05
Fibroblast - Dermal, donor2	11346-117G5	51.41	9.43	0.47
Fibroblast - Dermal, donor3	11418-118F5	53.07	8.70	2.54
Fibroblast - Dermal, donor4	11450-119A1	83.31	8.48	0.34
Fibroblast - Dermal, donor5	11454-119A5	81.82	14.65	0.00
Fibroblast - Dermal, donor6	11458-119A9	97.62	10.72	0.81
Fibroblast - Gingival, donor1	11237-116D4	66.43	9.16	1.25
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	61.31	6.29	2.62
Fibroblast - Gingival, donor2	11318-117D4	71.43	6.72	0.66
Fibroblast - Gingival, donor3	11394-118C8	68.16	6.67	0.58
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	42.59	3.12	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	37.53	4.58	0.70
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	80.60	10.29	0.94
Fibroblast - Gingival, donor6 (control)	11922-125H5	62.75	7.03	1.08
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	26.47	2.12	0.71
Fibroblast - Gingival, donor7 (control)	11924-125H7	76.19	10.38	1.17
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	57.81	8.73	1.50
Fibroblast - Gingival, donor8 (control)	11926-125H9	90.50	12.61	1.54
Fibroblast - Gingival, donor9 (control)	11927-125I1	63.98	5.58	1.32
Fibroblast - Lung, donor1	11270-116H1	13.59	1.36	0.00
Fibroblast - Lung, donor2	11347-117G6	50.73	4.48	2.98
Fibroblast - Lung, donor3	11419-118F6	56.14	8.86	0.84
Fibroblast - Lymphatic, donor1	11506-119G3	40.82	5.00	3.33
Fibroblast - Lymphatic, donor2	11586-120G2	43.36	1.40	1.40
Fibroblast - Lymphatic, donor3	11667-122G2	10.36	0.84	0.56
Fibroblast - Mammary, donor1	11540-120B1	57.65	8.93	0.41
Fibroblast - Mammary, donor2	11620-122A9	19.97	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	65.52	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	73.52	10.09	0.58
Fibroblast - Periodontal Ligament, donor2	11319-117D5	96.17	10.77	0.91
Fibroblast - Periodontal Ligament, donor3	11395-118C9	94.24	11.02	1.84
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	67.55	7.63	0.76
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	51.57	5.13	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	42.56	3.60	0.23
Fibroblast - Pulmonary Artery, donor1	11250-116E8	57.81	11.38	0.44
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	46.94	4.47	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	24.72	4.01	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	43.49	3.95	1.19
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	35.32	6.75	2.18
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	49.38	5.33	1.07
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	54.40	10.45	1.38
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	24.97	4.51	1.81
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	92.30	11.55	1.94
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	32.90	2.78	1.27
Fibroblast - skin normal, donor1	11553-120C5	51.36	4.59	1.31
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	48.32	7.82	2.41
Fibroblast - skin normal, donor2	11561-120D4	84.99	9.85	1.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	33.25	4.53	3.63
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	48.55	6.96	1.66
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	63.42	4.62	2.22
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	23.98	5.91	0.66
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	85.96	8.31	1.07
Fibroblast - skin walker warburg, donor1	11554-120C6	58.70	8.77	1.18
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	58.65	5.49	0.47
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	576.15	199.44	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	95.87	10.46	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	56.86	15.95	1.56
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	70.79	16.13	1.04
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	84.32	21.46	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	55.12	27.56	2.30
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	65.72	38.28	1.91
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	174.01	69.32	2.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	124.64	14.34	1.10
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	83.34	18.49	1.37
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	121.85	38.04	1.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	113.14	16.65	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	105.35	16.63	1.96
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	140.63	52.62	1.77
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	113.62	60.91	1.55
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	102.21	44.21	2.71
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	97.24	53.73	3.22
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	84.37	28.87	1.86
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	128.32	59.94	4.84
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	107.75	64.45	4.88
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	59.55	16.43	2.51
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	84.83	30.27	2.87
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	123.28	44.81	6.34
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	54.07	15.07	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	70.58	25.59	1.11
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	90.26	29.27	3.80
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	50.41	11.49	0.60
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	69.21	21.88	1.36
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	78.12	28.64	2.39
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	46.41	9.05	0.62
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	42.52	10.08	1.37
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	62.41	12.39	0.66
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	64.89	21.55	1.41
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	65.95	21.85	1.84
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	47.04	7.63	1.03
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	55.69	10.49	0.35
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	56.70	10.17	1.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	38.35	5.73	0.88
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	54.98	8.73	0.98
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	60.62	12.16	1.46
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	43.30	11.87	1.60
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	55.62	9.10	0.57
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	45.08	7.43	0.47
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	38.01	6.69	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	54.88	8.89	0.63
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	41.06	7.25	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	40.12	6.45	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	56.20	10.28	1.48
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	46.53	8.29	0.80
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	53.55	12.85	1.22
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	48.71	11.53	0.78
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	55.84	7.59	0.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	50.33	5.90	0.37
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	39.70	5.70	0.88
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	59.50	8.93	1.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	46.83	6.07	0.53
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	44.59	5.45	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	50.32	8.90	1.27
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	172.98	66.49	1.99
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	111.55	47.15	2.62
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	126.23	60.15	2.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	73.23	41.31	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	65.27	27.13	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	103.31	44.74	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	74.24	37.12	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	90.90	52.99	1.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	89.85	43.32	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	92.16	20.87	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	82.35	41.01	1.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	82.36	35.00	1.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	66.65	33.32	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	82.22	27.41	0.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	86.29	25.49	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	76.33	24.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	82.06	22.58	0.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	79.82	27.85	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	85.61	10.44	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	79.61	12.03	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	55.94	14.80	0.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	66.07	22.02	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	88.23	32.31	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	82.62	25.54	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	63.22	26.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	62.27	23.83	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	69.11	15.65	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	70.90	11.37	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	57.40	16.57	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	88.67	43.13	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	54.67	19.88	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	70.31	13.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	58.54	10.26	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	64.60	8.65	1.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	70.59	13.56	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	76.47	20.23	1.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	63.74	18.89	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	51.93	18.09	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	57.93	15.36	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	55.95	18.65	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	51.33	8.36	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	54.35	14.56	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	17.12	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	34.10	1.25	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	25.86	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	28.54	1.59	2.54
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	26.74	4.18	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	44.33	10.10	1.04
Hep-2 cells mock treated, biol_rep2	11899-125E9	49.12	11.98	0.68
Hep-2 cells mock treated, biol_rep3	11900-125F1	44.14	10.69	1.14
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	42.30	8.53	0.87
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	45.99	9.46	0.64
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	51.67	11.84	1.08
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	44.09	8.47	1.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	40.66	9.26	0.51
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	44.53	10.89	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	30.78	4.48	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	19.91	3.03	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	60.81	5.29	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	34.57	4.23	1.76
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	23.25	0.73	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	51.58	8.39	0.52
Hepatocyte, donor1	11523-119I2	64.16	1.21	0.00
Hepatocyte, donor2	11603-120I1	48.48	9.70	0.00
Hepatocyte, donor3	11684-122I1	48.47	4.91	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	77.02	20.89	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	72.01	28.84	0.52
Iris Pigment Epithelial Cells, donor1	11530-119I9	64.62	10.70	1.92
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	31.84	3.18	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	60.08	6.68	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	31.84	13.84	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	40.04	2.50	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	11.87	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	20.50	20.50	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	22.85	4.57	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	37.36	4.87	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	21.67	11.67	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	29.04	14.52	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	41.03	17.21	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	22.17	7.76	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	10.48	15.71	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	30.23	20.16	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	35.57	23.20	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	43.90	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	24.55	20.03	1.29
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	37.03	17.71	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	71.69	131.43	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	31.78	14.67	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	14.69	5.46	0.84
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	43.12	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	32.15	20.09	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	33.24	4.62	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	90.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	24.07	7.55	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	18.14	6.35	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	44.23	44.23	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	38.74	8.61	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	36.84	10.16	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	32.86	32.86	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	29.33	8.93	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	29.16	9.11	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	26.42	9.28	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	33.18	33.18	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	27.78	14.20	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	28.10	8.78	1.76
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	25.15	9.43	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	22.25	10.43	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	42.05	13.28	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	38.90	9.73	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	27.90	7.85	1.74
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	22.50	9.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	34.85	6.97	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	22.40	8.53	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	33.25	8.31	4.16
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	28.50	8.55	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	24.85	5.52	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	48.41	6.05	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	18.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	21.15	2.11	0.00
Keratinocyte - epidermal, donor1	11272-116H3	36.31	11.18	0.82
Keratinocyte - epidermal, donor2	11349-117G8	24.01	2.34	1.17
Keratinocyte - epidermal, donor3	11421-118F8	75.72	10.89	0.19
Keratinocyte - oral, donor1	11251-116E9	74.35	17.94	1.14
Keratocytes, donor1	11527-119I6	48.82	6.88	0.00
Keratocytes, donor2	11607-120I5	32.81	5.86	0.00
Keratocytes, donor3	11688-122I5	40.71	5.14	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	197.81	28.57	0.00
Lens Epithelial Cells, donor1	11529-119I8	53.94	16.18	1.08
Lens Epithelial Cells, donor2	11609-120I7	78.31	9.46	0.58
Lens Epithelial Cells, donor3	11690-122I7	85.27	14.23	2.32
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	33.79	4.15	0.71
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	21.49	3.35	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	34.16	6.45	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	22.05	2.69	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	23.95	2.52	0.95
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	17.25	2.26	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	35.70	7.39	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	12.89	2.28	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	17.88	3.66	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	27.29	3.96	1.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	19.78	4.85	1.36
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	9.26	1.30	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	33.10	4.53	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	20.75	4.53	0.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	16.76	2.33	0.27
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	32.95	4.62	1.23
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	13.40	1.25	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	18.12	2.74	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	35.54	5.27	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	8.49	3.81	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	11.20	1.24	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	30.55	4.85	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	22.08	4.31	0.54
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	20.44	3.18	0.91
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	22.29	3.63	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	32.25	4.19	0.84
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	17.14	2.41	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	30.95	5.50	2.06
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	15.99	2.45	0.56
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	11.98	2.54	0.32
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	28.59	5.33	1.94
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	12.90	2.98	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	13.01	2.48	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	43.31	5.55	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	20.75	3.71	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	13.61	1.51	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	35.38	4.82	0.96
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	27.09	4.56	0.91
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	28.83	4.62	0.70
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	22.76	3.20	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	10.67	2.91	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	10.11	1.24	0.31
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	32.23	4.66	0.72
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	18.62	2.61	0.98
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	11.30	2.35	0.47
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	34.90	5.57	0.99
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	11.01	2.05	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	19.09	2.69	0.60
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	47.59	9.06	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	52.17	9.97	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	37.85	6.68	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	30.47	8.46	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	33.06	5.63	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	32.69	4.67	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	24.22	10.31	1.55
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	40.44	8.33	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	30.76	7.46	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	41.01	10.47	0.87
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	52.67	5.40	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	32.25	7.99	0.41
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	27.73	10.27	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	58.93	8.82	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	37.31	17.99	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	33.62	7.64	1.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	60.83	11.74	0.80
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	52.53	11.90	0.38
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	31.29	14.73	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	50.56	9.79	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	56.43	12.49	1.46
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	49.61	10.93	1.96
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	44.30	9.27	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	50.22	9.29	0.87
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	40.36	13.15	0.60
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	58.09	13.83	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	41.36	8.48	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	35.40	9.22	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	33.39	4.61	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	33.00	9.21	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	28.31	7.36	1.70
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	44.31	10.67	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	41.12	7.23	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	31.60	12.93	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	41.08	10.46	1.49
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	39.76	8.55	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	41.35	7.75	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	57.37	6.85	1.71
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	47.98	9.00	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	38.01	6.03	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	40.53	14.22	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	40.90	8.25	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	27.37	10.73	1.07
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	35.01	7.41	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	40.00	10.37	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	39.54	4.65	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	33.85	8.46	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	36.01	9.60	1.20
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	32.71	7.27	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	43.69	6.13	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	33.54	7.40	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	31.99	9.41	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	43.24	5.53	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	33.80	7.21	1.80
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	22.37	10.33	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	48.10	7.57	1.34
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	44.19	5.87	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	32.99	7.26	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	41.00	8.82	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	45.07	10.06	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	32.99	10.62	2.24
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	46.81	14.57	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	52.46	10.41	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	34.94	8.61	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	40.85	15.38	0.96
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	40.15	11.93	1.19
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	31.60	9.11	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	30.43	10.38	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	51.68	11.78	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	29.95	9.81	1.03
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	36.28	7.26	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	50.70	14.89	0.63
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	32.52	12.26	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	42.53	6.32	1.72
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	39.60	5.14	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	26.88	8.49	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	41.99	6.24	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	37.03	8.74	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	23.49	7.83	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	48.44	7.52	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	36.71	6.97	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	26.76	12.04	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	49.19	14.44	1.07
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	34.35	9.70	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	36.71	8.26	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	42.68	8.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	46.16	7.41	1.14
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	36.81	6.90	2.30
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	38.85	12.04	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	40.54	5.79	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	39.77	8.84	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	47.74	8.62	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	45.73	10.39	0.00
Macrophage - monocyte derived, donor1	11232-116C8	33.50	0.23	0.00
Macrophage - monocyte derived, donor2	11313-117C8	40.74	1.47	0.37
Macrophage - monocyte derived, donor3	11389-118C3	45.62	3.01	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	46.73	9.03	0.53
Mallassez-derived cells, donor2	11929-125I3	76.06	16.64	1.11
Mallassez-derived cells, donor3	11930-125I4	77.69	21.68	1.53
Mammary Epithelial Cell, donor1	11273-116H4	68.65	20.83	0.90
Mammary Epithelial Cell, donor2	11350-117G9	59.07	17.08	1.45
Mammary Epithelial Cell, donor3	11422-118F9	26.94	2.99	0.25
Mast cell - stimulated, donor1	11487-119E2	86.78	7.46	0.68
Mast cell, donor1	11563-120D6	71.91	8.22	3.68
Mast cell, donor2	11565-120D8	62.70	2.38	1.19
Mast cell, donor3	11566-120D9	71.36	2.93	3.15
Mast cell, donor4	11567-120E1	58.51	3.55	1.42
Mast cell, expanded and stimulated, donor5	11940-126A5	72.75	6.43	2.11
Mast cell, expanded and stimulated, donor8	11942-126A7	27.43	5.84	4.67
Mast cell, expanded, donor5	11939-126A4	54.95	3.90	1.61
Mast cell, expanded, donor8	11941-126A6	44.85	3.01	2.51
Melanocyte - dark, donor1	11502-119F8	64.87	6.27	1.39
Melanocyte - dark, donor2	11582-120F7	44.99	6.92	0.35
Melanocyte - dark, donor3	11663-122F7	60.34	7.97	0.14
Melanocyte - light, donor1	11274-116H5	14.81	4.00	0.24
Melanocyte - light, donor2	11351-117H1	10.92	2.73	0.00
Melanocyte - light, donor3	11423-118G1	13.88	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	50.08	11.25	0.31
Melanocyte, donor2 (MC+2)	12739-135I3	40.88	8.07	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	36.96	6.16	0.27
Meningeal Cells, donor1	11493-119E8	69.23	7.07	0.99
Meningeal Cells, donor2	11573-120E7	84.95	11.88	1.32
Meningeal Cells, donor3	11654-122E7	73.11	16.30	1.14
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	71.00	10.55	2.57
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	44.68	7.55	1.91
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	7.88	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	13.08	2.62	2.62
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	56.69	10.05	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	41.51	2.96	1.06
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	49.76	3.52	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	36.70	4.61	0.66
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	41.64	5.11	2.92
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	33.96	3.89	1.02
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	59.70	5.40	1.66
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	13.75	1.12	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	34.08	5.39	0.79
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	11.57	1.48	2.08
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	2.34	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	35.22	5.12	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	84.00	13.82	0.71
Mesenchymal stem cells - hepatic, donor0	11218-116B3	46.91	4.38	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	66.04	9.43	0.00
Mesothelial Cells, donor1	11247-116E5	50.12	6.10	1.06
Mesothelial Cells, donor2	12156-128G5	44.54	5.00	0.50
Mesothelial Cells, donor3	11402-118D7	44.30	5.49	1.01
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	74.27	9.45	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	63.79	3.45	0.49
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	43.58	2.94	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	79.51	3.46	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	52.38	2.17	1.55
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	29.66	2.70	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	44.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	48.05	3.25	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	45.15	1.40	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	38.93	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	44.50	2.64	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	34.84	3.56	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	59.86	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	26.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	31.91	1.14	0.76
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	52.64	1.32	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	33.32	1.06	0.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	30.39	2.76	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	30.10	2.09	0.89
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	28.50	1.68	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	67.90	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	23.33	2.26	0.50
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	33.75	2.14	0.95
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	44.78	1.66	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	22.56	2.07	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	28.40	2.10	0.63
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	20.59	1.63	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	27.46	1.72	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	27.56	2.22	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	20.64	10.32	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	22.56	2.63	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	36.50	1.52	1.52
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	33.14	6.63	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	31.80	1.90	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	29.11	3.23	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	19.63	4.36	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	16.34	0.96	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	26.42	0.40	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	26.05	1.37	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	20.02	2.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	24.46	6.12	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	19.27	1.31	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	46.35	1.10	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	40.98	0.64	0.64
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	21.57	1.74	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	40.36	3.48	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	48.62	8.84	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	24.62	0.68	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	30.63	1.31	0.88
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	31.25	1.78	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	22.44	0.28	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	36.58	5.40	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	33.22	1.17	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	22.62	3.02	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	25.04	3.34	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	36.09	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	25.86	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	34.72	4.55	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	29.02	2.35	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	16.59	2.07	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	40.32	1.29	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	38.75	0.64	1.27
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	20.82	2.14	0.80
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	39.81	4.19	0.60
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	24.72	2.26	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	17.84	0.64	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	42.24	3.10	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	38.68	2.28	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	22.73	1.42	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	28.02	2.21	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	34.54	3.26	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	28.81	2.06	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	38.92	4.04	0.86
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	29.67	2.89	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	33.35	2.08	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	37.67	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	35.65	1.78	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	41.73	1.97	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	34.71	2.10	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	35.78	1.19	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	74.51	1.86	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	46.57	2.63	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	25.57	0.80	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	34.16	0.45	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	22.84	0.00	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	39.94	0.73	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	23.33	3.11	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	8.55	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	3.86	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	14.14	2.02	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	10.54	0.00	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	5.45	1.36	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	0.64	0.00	1.27
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	4.86	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	6.04	1.51	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	39.97	11.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	42.41	6.52	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	14.26	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	50.20	12.55	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	51.49	6.68	1.94
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	56.96	4.70	1.05
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	53.40	8.68	2.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	68.03	7.93	1.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	133.29	13.31	5.13
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	164.37	15.96	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	40.12	2.72	4.08
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	198.47	33.08	3.68
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	41.02	6.28	2.09
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	79.26	10.46	2.09
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	38.64	7.03	1.35
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	59.50	7.36	2.31
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	289.50	55.67	11.13
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	32.26	4.96	0.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	56.30	6.23	1.62
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	37.86	5.44	0.68
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	51.77	5.72	1.14
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	54.68	5.10	1.64
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	34.48	3.18	1.59
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	22.21	4.80	1.80
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	59.40	10.50	7.22
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	39.84	3.25	2.44
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	62.79	9.35	1.94
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	32.35	4.22	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	51.03	7.82	1.84
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	51.42	6.43	1.29
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	73.81	9.31	6.21
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	242.73	35.40	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	69.06	7.35	1.56
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	45.73	7.62	2.54
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	68.36	5.70	1.42
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	47.22	6.01	1.72
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	397.22	36.11	27.08
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	69.64	4.33	1.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	60.87	5.41	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	40.08	3.57	1.19
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	33.43	7.43	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	93.08	7.95	0.76
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	45.30	7.17	2.28
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	57.52	2.61	2.61
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	97.69	10.85	1.36
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	40.57	5.29	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	33.24	2.66	1.33
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	57.54	7.94	2.98
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	62.78	4.98	2.68
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	57.46	3.63	1.81
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	64.76	7.29	1.33
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	27.11	6.10	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	204.38	20.44	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	76.21	8.54	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	74.59	5.67	1.26
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	42.98	4.24	0.91
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	42.72	7.91	1.58
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	104.30	6.80	4.53
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	278.18	25.29	0.00
Myoblast, donor1	11241-116D8	55.78	11.93	2.11
Myoblast, donor2	11322-117D8	59.45	8.25	2.11
Myoblast, donor3	11398-118D3	66.93	9.92	2.02
NK T cell leukemia cell line:KHYG-1	10777-110G3	98.21	17.95	1.17
Natural Killer Cells, donor1	11230-116C6	83.03	7.38	4.92
Natural Killer Cells, donor2	11311-117C6	65.44	9.05	4.82
Natural Killer Cells, donor3	11387-118C1	66.44	6.81	4.42
Neural stem cells, donor1	11275-116H6	72.95	14.52	2.18
Neural stem cells, donor2	11352-117H2	84.73	19.26	0.00
Neurons, donor1	11494-119E9	66.00	5.69	0.00
Neurons, donor2	11574-120E8	66.93	5.94	0.88
Neurons, donor3	11655-122E8	69.06	8.22	0.82
Neutrophils, donor1	11233-116C9	71.46	1.86	0.00
Neutrophils, donor2	11314-117C9	52.18	2.90	0.00
Neutrophils, donor3	11390-118C4	86.13	1.83	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	62.45	11.40	4.16
Nucleus Pulposus Cell, donor2	11409-118E5	28.33	1.95	1.63
Nucleus Pulposus Cell, donor3	11462-119B4	68.99	6.02	0.20
Olfactory epithelial cells, donor1	11933-125I7	34.83	2.06	0.69
Olfactory epithelial cells, donor2	11934-125I8	47.91	4.78	1.16
Olfactory epithelial cells, donor3	11935-125I9	36.32	4.09	0.91
Olfactory epithelial cells, donor4	11936-126A1	39.54	3.12	0.78
Oligodendrocyte - precursors, donor1	11496-119F2	75.23	18.05	1.20
Osteoblast - differentiated, donor1	11276-116H7	35.09	2.55	1.28
Osteoblast - differentiated, donor2	11353-117H3	17.15	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	31.66	3.10	0.62
Osteoblast, donor1	11277-116H8	29.12	3.91	0.39
Osteoblast, donor2	11354-117H4	92.00	17.56	0.70
Osteoblast, donor3	11426-118G4	59.01	6.93	0.18
Pancreatic stromal cells, donor1	11249-116E7	58.88	8.00	1.85
Pericytes, donor1	11491-119E6	12.80	0.11	0.45
Pericytes, donor2	11571-120E5	22.64	2.26	0.45
Pericytes, donor3	11652-122E5	29.09	3.87	1.22
Perineurial Cells, donor1	11499-119F5	62.27	7.35	0.90
Perineurial Cells, donor2	11579-120F4	72.50	11.50	2.21
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	71.72	5.42	3.19
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	36.48	4.16	1.71
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	50.99	4.27	2.07
Placental Epithelial Cells, donor1	11278-116H9	20.09	3.83	0.48
Placental Epithelial Cells, donor2	11355-117H5	29.94	5.54	0.00
Placental Epithelial Cells, donor3	11427-118G5	28.47	3.73	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	31.01	1.90	0.32
Preadipocyte - breast, donor1	11467-119B9	25.14	4.50	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	20.49	3.52	1.17
Preadipocyte - breast, donor2	11328-117E5	39.63	4.50	0.68
Preadipocyte - omental, donor1	11468-119C1	39.11	8.95	1.07
Preadipocyte - omental, donor2	11329-117E6	47.58	5.67	1.31
Preadipocyte - omental, donor3	11403-118D8	49.85	8.88	1.58
Preadipocyte - perirenal, donor1	11469-119C2	33.47	1.97	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	19.35	3.07	3.07
Preadipocyte - subcutaneous, donor2	11356-117H6	84.11	14.87	0.71
Preadipocyte - subcutaneous, donor3	11428-118G6	63.35	8.85	1.53
Preadipocyte - visceral, donor1	11280-116I2	73.40	12.67	1.96
Preadipocyte - visceral, donor2	11357-117H7	57.06	11.50	1.38
Preadipocyte - visceral, donor3	11429-118G7	72.41	10.24	1.46
Prostate Epithelial Cells (polarized), donor1	11253-116F2	57.02	26.10	0.60
Prostate Epithelial Cells, donor2	11331-117E8	40.62	11.51	0.68
Prostate Epithelial Cells, donor3	11404-118D9	42.56	7.29	0.24
Prostate Stromal Cells, donor1	11254-116F3	57.29	8.77	0.23
Prostate Stromal Cells, donor2	11332-117E9	65.98	13.63	1.08
Prostate Stromal Cells, donor3	11405-118E1	42.13	5.21	0.31
Renal Cortical Epithelial Cells, donor1	11516-119H4	22.26	5.11	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	41.31	10.81	0.28
Renal Epithelial Cells, donor1	11517-119H5	22.83	3.04	0.00
Renal Epithelial Cells, donor2	11597-120H4	32.72	7.11	0.00
Renal Epithelial Cells, donor3	11678-122H4	55.47	16.20	1.16
Renal Glomerular Endothelial Cells, donor1	11514-119H2	23.15	2.04	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	42.59	4.31	1.35
Renal Glomerular Endothelial Cells, donor3	11675-122H1	85.47	13.99	1.11
Renal Glomerular Endothelial Cells, donor4	11783-124B1	9.32	0.67	0.67
Renal Mesangial Cells, donor1	11518-119H6	21.79	3.74	0.66
Renal Mesangial Cells, donor2	11598-120H5	26.33	8.15	1.25
Renal Mesangial Cells, donor3	11679-122H5	13.32	1.39	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	49.93	8.86	0.54
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	32.47	4.64	0.84
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	35.10	4.63	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	68.71	9.33	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	40.65	6.25	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	21.61	4.12	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	28.85	5.77	0.75
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	50.78	2.41	0.40
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	47.35	24.12	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	35.77	20.91	2.75
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	79.47	25.52	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	112.21	25.22	1.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	65.94	17.48	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	60.45	19.07	1.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	125.66	24.56	1.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	68.41	15.15	1.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	60.56	18.72	2.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	69.41	21.49	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	64.90	17.85	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	59.31	17.92	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	67.14	16.35	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	57.20	11.80	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	63.28	16.82	1.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	60.79	26.76	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	72.95	18.07	0.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	55.81	19.35	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	98.34	22.56	0.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	70.96	16.16	0.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	62.83	16.42	1.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	90.13	20.40	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	41.49	13.45	1.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	63.40	17.60	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	82.05	24.98	1.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	65.61	12.75	1.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	72.40	19.21	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	51.18	22.41	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	56.35	15.08	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	72.73	16.84	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	65.11	20.11	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	54.42	16.15	1.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	65.80	16.50	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	78.19	23.01	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	90.43	21.29	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	72.68	21.01	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	67.06	20.63	1.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	82.58	20.85	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	80.61	23.31	1.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	65.27	16.36	2.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	73.39	15.83	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	65.84	14.66	1.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	74.53	15.90	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	50.72	10.24	0.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	75.17	19.55	1.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	54.81	13.56	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	55.55	16.07	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	65.58	17.83	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	54.22	12.85	1.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	77.14	30.57	1.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	59.63	11.56	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	50.64	12.06	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	38.23	15.38	1.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	55.71	17.07	1.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	55.85	16.77	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	50.59	17.93	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	53.49	21.64	1.80
Schwann Cells, donor1	11498-119F4	31.97	2.44	0.19
Schwann Cells, donor2	11578-120F3	61.24	3.40	0.00
Schwann Cells, donor3	11659-122F3	47.76	6.13	0.88
Sebocyte, donor1	11220-116B5	52.59	8.76	1.64
Sebocyte, donor2	11301-117B5	28.03	7.35	0.46
Sebocyte, donor3	11378-118B1	23.50	2.47	0.41
Sertoli Cells, donor1	11255-116F4	86.14	19.88	0.00
Sertoli Cells, donor2	11333-117F1	33.89	11.30	0.00
Skeletal Muscle Cells, donor1	11281-116I3	50.59	6.42	0.26
Skeletal Muscle Cells, donor2	11358-117H8	16.63	3.61	0.72
Skeletal Muscle Cells, donor3	11430-118G8	40.97	5.02	0.84
Skeletal Muscle Cells, donor4	11451-119A2	78.55	16.65	1.73
Skeletal Muscle Cells, donor5	11455-119A6	72.39	12.93	0.89
Skeletal Muscle Cells, donor6	11459-119B1	95.11	12.31	0.77
Skeletal Muscle Satellite Cells, donor1	11240-116D7	73.46	14.74	2.90
Skeletal Muscle Satellite Cells, donor2	11321-117D7	61.07	7.28	1.71
Skeletal Muscle Satellite Cells, donor3	11397-118D2	96.33	15.28	1.09
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	60.49	9.18	1.18
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	32.57	7.96	2.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	27.79	2.75	1.24
Skin - palm, donor1	10286-104F7	104.76	5.37	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	31.57	6.20	0.58
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	97.33	32.72	13.90
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	35.70	7.53	0.39
Small Airway Epithelial Cells, donor1	11256-116F5	47.40	11.68	0.56
Small Airway Epithelial Cells, donor2	11334-117F2	61.19	13.78	0.84
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	87.75	20.51	6.98
Small Airway Epithelial Cells, donor3	11406-118E2	58.46	9.67	0.30
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	38.57	5.86	0.93
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	31.13	6.00	2.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	42.32	1.76	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	24.75	3.76	1.33
Smooth Muscle Cells - Aortic, donor2	11360-117I1	24.81	3.15	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	36.31	3.86	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	26.02	4.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	29.81	4.79	0.80
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	58.96	8.64	1.33
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	61.97	10.50	0.38
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	48.84	8.47	1.63
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	65.56	7.09	0.89
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	45.13	6.41	0.57
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	14.32	2.11	1.14
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	51.75	2.74	1.52
Smooth Muscle Cells - Carotid, donor1	11285-116I7	23.99	0.51	0.76
Smooth Muscle Cells - Carotid, donor2	11362-117I3	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	27.18	4.29	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	35.98	6.34	1.03
Smooth Muscle Cells - Colonic, donor2	11320-117D6	42.19	5.60	1.08
Smooth Muscle Cells - Colonic, donor3	11396-118D1	59.20	8.82	0.73
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	23.67	4.95	0.46
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	20.48	3.23	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	45.13	5.38	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	19.12	4.10	1.02
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	37.54	7.62	1.26
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	46.09	10.67	1.21
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	54.84	10.01	0.68
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	17.51	1.81	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	121.87	23.31	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	66.58	8.26	0.93
Smooth Muscle Cells - Prostate, donor2	11335-117F3	53.34	7.39	1.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	32.47	0.51	1.01
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	47.95	5.43	0.75
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	33.01	6.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	32.31	2.58	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	30.23	1.86	0.93
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	40.90	6.56	2.02
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	29.46	6.27	0.63
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	17.11	2.65	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	104.55	13.00	1.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	50.45	6.54	0.93
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	28.78	5.18	0.72
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	34.67	3.82	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	29.52	3.57	0.38
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	77.14	9.92	1.12
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	62.25	6.95	1.51
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	7.62	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	31.32	4.65	0.73
Smooth Muscle Cells - Uterine, donor1	11258-116F7	68.49	10.16	2.65
Smooth Muscle Cells - Uterine, donor3	11466-119B8	35.99	6.44	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	33.43	5.64	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	29.88	6.08	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	27.15	8.93	1.86
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	48.15	6.47	2.87
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	42.30	12.49	1.14
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	72.08	12.21	1.18
Smooth muscle cells - airway, control, donor1	11966-126D4	40.38	6.35	0.76
Smooth muscle cells - airway, control, donor2	11967-126D5	37.94	3.59	2.40
Smooth muscle cells - airway, control, donor3	11968-126D6	35.11	5.43	1.25
Smooth muscle cells - airway, control, donor4	11969-126D7	37.13	3.67	1.83
Synoviocyte, donor1	11291-117A4	34.51	4.88	0.50
Synoviocyte, donor2	11368-117I9	42.58	2.85	1.51
Synoviocyte, donor3	11440-118H9	44.46	4.47	0.67
Trabecular Meshwork Cells, donor1	11532-120A2	35.02	6.43	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	31.71	3.96	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	28.94	3.24	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	36.77	7.81	0.22
Tracheal Epithelial Cells, donor2	11369-118A1	26.67	4.25	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	22.33	8.02	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	51.92	4.06	0.25
Urethra, donor2	10319-105A4	61.15	5.40	1.80
Urothelial Cells, donor1	11520-119H8	23.64	3.19	1.06
Urothelial Cells, donor2	11600-120H7	16.42	2.40	0.00
Urothelial Cells, donor3	11681-122H7	15.36	2.06	0.92
Urothelial cells, donor0	11216-116B1	53.49	8.69	0.45
Whole blood (ribopure), donor090309, donation1	12179-129A1	80.08	5.34	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	81.49	5.72	7.15
Whole blood (ribopure), donor090309, donation3	12181-129A3	49.97	2.74	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	49.24	2.41	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	48.23	2.32	1.74
Whole blood (ribopure), donor090612, donation1	12182-129A4	71.85	5.21	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	63.33	2.75	2.75
Whole blood (ribopure), donor090612, donation3	12184-129A6	43.82	0.91	1.83
Wilms' tumor cell line:G-401	10809-111A8	80.68	10.86	1.23
Wilms' tumor cell line:HFWT	10597-108E3	116.17	7.92	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	124.86	27.65	1.12
achilles tendon, donor2	10292-104G4	43.40	0.00	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	94.84	36.20	0.51
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	106.57	31.58	0.46
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	81.08	14.48	0.83
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	148.30	26.94	2.18
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	109.06	18.83	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	60.48	11.00	2.54
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	97.18	37.57	5.17
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	97.38	15.86	5.73
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	83.31	19.60	4.90
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	114.94	21.36	3.11
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	93.10	18.22	0.55
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	148.22	19.50	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	104.57	16.96	2.09
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	108.48	31.59	0.78
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	101.41	14.32	0.88
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	60.88	13.01	0.93
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	62.92	14.81	0.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	78.89	6.75	0.92
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	64.01	5.12	1.28
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	57.63	6.37	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	66.43	6.50	1.44
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	66.60	15.15	1.11
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	111.74	18.35	0.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	163.52	52.03	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	106.22	21.09	2.64
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	95.51	20.50	3.49
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	108.72	54.36	0.00
adenocarcinoma cell line:IM95m	10796-110I4	96.08	16.01	0.00
adipose tissue, adult, pool1	10010-101C1	36.92	2.02	0.00
adipose, donor1	10184-103D4	194.10	33.43	1.76
adipose, donor2	10185-103D5	57.58	8.52	1.62
adipose, donor3	10186-103D6	74.61	16.34	1.91
adipose, donor4	10187-103D7	94.48	39.00	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	191.44	20.36	1.58
adrenal gland, adult, pool1	10081-102A9	58.20	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	38.69	8.27	0.80
alveolar cell carcinoma cell line:SW 1573	10708-109H6	109.33	19.29	1.07
amniotic membrane cells, donor1	12235-129G3	76.97	5.56	0.46
amniotic membrane cells, donor2	12236-129G4	77.43	16.91	1.69
amniotic membrane cells, donor3	12237-129G5	84.26	11.78	0.00
amygdala - adult, donor10196	10167-103B5	61.66	10.67	1.19
amygdala, adult, donor10252	10151-102I7	74.21	5.27	1.62
amygdala, newborn, donor10223	10360-105E9	50.67	6.78	2.58
anaplastic carcinoma cell line:8305C	10428-106D5	58.19	19.23	1.40
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	95.75	15.22	3.97
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	87.85	18.71	1.67
aorta, adult, pool1	10052-101G7	43.93	1.37	1.18
appendix, adult	10189-103D9	88.49	6.60	1.55
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	91.49	34.39	7.57
artery, adult	10190-103E1	51.63	6.79	0.00
astrocytoma cell line:TM-31	10425-106D2	71.85	11.88	0.72
b cell line:RPMI1788	10427-106D4	59.78	8.03	1.34
basal cell carcinoma cell line:TE 354.T	10702-109G9	53.55	6.94	1.94
bile duct carcinoma cell line:HuCCT1	10432-106D9	86.83	24.31	0.99
bile duct carcinoma cell line:TFK-1	10496-107C1	83.19	12.22	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	61.52	10.63	0.56
bladder, adult, pool1	10011-101C2	52.80	1.85	0.65
blood, adult, pool1	10053-101G8	37.65	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	62.51	4.28	0.00
bone marrow, adult	10192-103E3	46.56	2.70	2.02
brain, adult, donor1	10084-102B3	47.15	3.08	0.00
brain, adult, pool1	10012-101C3	57.35	4.12	0.78
brain, fetal, pool1	10085-102B4	40.07	2.67	0.00
breast carcinoma cell line:MCF7	10482-107A5	129.50	30.72	2.31
breast carcinoma cell line:MDA-MB-453	10419-106C5	91.50	22.84	1.00
breast, adult, donor1	10080-102A8	51.14	2.53	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	142.92	22.61	1.78
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	77.00	21.03	0.93
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	151.25	12.89	5.06
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	73.11	8.96	0.73
carcinoid cell line:NCI-H1770	10703-109H1	55.48	5.17	0.00
carcinoid cell line:NCI-H727	10735-110B6	213.18	45.28	0.98
carcinoid cell line:SK-PN-DW	10719-109I8	66.23	13.94	0.63
carcinosarcoma cell line:JHUCS-1	10642-109A3	98.49	10.11	2.66
caudate nucleus - adult, donor10196	10177-103C6	71.38	2.30	1.15
caudate nucleus, adult, donor10252	10164-103B2	62.58	2.34	0.84
caudate nucleus, adult, donor10258	10379-105H1	77.94	3.06	2.29
caudate nucleus, newborn, donor10223	10354-105E3	45.05	7.32	2.20
cerebellum - adult, donor10196	10173-103C2	87.40	2.91	0.00
cerebellum, adult, donor10252	10166-103B4	74.73	3.42	0.64
cerebellum, adult, pool1	10083-102B2	48.64	1.03	1.03
cerebellum, newborn, donor10223	10357-105E6	54.80	12.45	1.66
cerebral meninges, adult	10188-103D8	72.62	5.04	0.50
cerebrospinal fluid, donor2	10294-104G6	52.62	3.65	0.00
cervical cancer cell line:D98-AH2	10552-107I3	42.70	8.91	0.58
cervical cancer cell line:ME-180	10553-107I4	50.38	20.22	0.99
cervix, adult, pool1	10013-101C4	54.91	4.30	0.42
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	69.39	10.87	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	86.21	6.53	0.00
choriocarcinoma cell line:BeWo	10423-106C9	80.78	21.50	0.25
choriocarcinoma cell line:SCH	10785-110H2	70.97	8.62	0.49
choriocarcinoma cell line:T3M-3	10618-108G6	56.21	4.74	0.00
chorionic membrane cells, donor1	12238-129G6	53.28	6.27	0.00
chorionic membrane cells, donor2	12239-129G7	71.49	11.14	0.20
chorionic membrane cells, donor3	12240-129G8	81.87	14.84	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	53.52	15.15	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	80.49	13.45	1.34
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	105.38	22.60	3.38
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	69.85	29.28	0.51
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	74.50	25.64	0.73
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	84.50	30.95	1.63
chronic myelogenous leukemia cell line:K562	10454-106G4	103.65	35.04	2.06
chronic myelogenous leukemia cell line:KU812	10409-106B4	81.32	18.77	3.91
clear cell carcinoma cell line:JHOC-5	10638-108I8	80.92	9.83	0.46
clear cell carcinoma cell line:TEN	10636-108I6	95.08	15.96	0.52
colon carcinoma cell line:CACO-2	10513-107D9	78.53	27.27	1.10
colon carcinoma cell line:COLO-320	10420-106C6	112.12	22.80	1.14
colon, adult, donor1	10082-102B1	58.31	4.76	0.00
colon, adult, pool1	10014-101C5	51.23	4.11	0.47
colon, fetal, donor1	10070-101I7	51.29	4.33	1.24
common myeloid progenitor CMP, donor1	12130-128D6	229.18	18.33	0.00
common myeloid progenitor CMP, donor2	12134-128E1	50.07	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	56.09	19.12	6.37
cord blood derived cell line:COBL-a 24h infection	10453-106G3	51.77	16.75	4.98
cord blood derived cell line:COBL-a untreated	10449-106F8	60.49	18.61	5.92
corpus callosum, adult, pool1	10042-101F6	43.89	1.44	0.22
cruciate ligament, donor2	10295-104G7	57.54	6.48	1.62
diaphragm, fetal, donor1	10069-101I6	81.06	5.62	0.80
diencephalon, adult	10193-103E4	46.08	3.60	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	112.05	31.46	0.92
ductal cell carcinoma cell line:KLM-1	10438-106E6	146.94	47.70	3.08
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	77.99	29.13	5.78
ductus deferens, adult	10196-103E7	55.32	13.46	1.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	70.57	8.64	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	70.62	8.09	0.74
dura mater, adult, donor1	10041-101F5	44.51	2.06	0.66
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	46.19	33.09	0.44
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	75.95	24.93	0.72
embryonic pancreas cell line:1B2C6	10604-108F1	147.99	13.57	1.23
embryonic pancreas cell line:1C3D3	10605-108F2	85.36	7.57	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	132.76	9.57	0.00
embryonic pancreas cell line:2C6	10603-108E9	170.75	5.25	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	120.00	27.15	1.01
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	70.14	9.42	0.54
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	96.97	26.21	3.06
epidermoid carcinoma cell line:A431	10426-106D3	79.48	24.68	0.78
epidermoid carcinoma cell line:Ca Ski	10431-106D8	93.05	32.56	0.99
epididymis, adult	10197-103E8	61.12	4.40	0.42
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	121.88	6.39	2.48
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	66.85	3.54	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	85.84	21.89	1.83
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	94.98	22.05	1.77
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	97.91	21.73	1.57
esophagus, adult, pool1	10015-101C6	51.18	5.42	0.32
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	119.85	20.04	14.40
eye - muscle inferior rectus, donor1	10272-104E2	57.95	7.24	0.00
eye - muscle lateral, donor2	10298-104H1	65.23	6.31	0.00
eye - muscle medial, donor2	10299-104H2	98.22	7.44	0.00
eye - muscle superior, donor2	10297-104G9	56.18	3.44	0.00
eye - vitreous humor, donor1	10268-104D7	49.55	5.83	0.00
eye, fetal, donor1	10054-101G9	57.71	3.56	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	70.52	9.75	0.90
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	150.76	21.13	2.85
frontal lobe, adult, pool1	10040-101F4	81.35	9.57	1.97
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	114.09	14.41	3.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	69.95	6.67	0.09
gall bladder, adult	10198-103E9	57.46	2.90	0.48
gamma delta positive T cells, donor1	11937-126A2	83.75	3.22	3.76
gamma delta positive T cells, donor2	11938-126A3	53.41	3.73	4.11
gastric adenocarcinoma cell line:MKN1	10614-108G2	76.25	16.90	0.84
gastric adenocarcinoma cell line:MKN45	10612-108F9	156.86	26.50	0.58
gastric cancer cell line:AZ521	10549-107H9	151.00	19.84	1.31
gastric cancer cell line:GSS	10560-108A2	92.44	8.24	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	36.55	13.94	0.00
giant cell carcinoma cell line:LU65	10487-107B1	40.16	11.02	0.69
giant cell carcinoma cell line:Lu99B	10433-106E1	246.47	24.63	2.38
glassy cell carcinoma cell line:HOKUG	10688-109F4	99.27	13.22	0.50
glioblastoma cell line:A172, tech_rep1	10444-106F3	66.60	8.66	1.16
glioblastoma cell line:A172, tech_rep2	10444-106F3	93.67	11.09	0.56
glioblastoma cell line:T98G	10485-107A8	49.56	6.18	0.88
glioma cell line:GI-1	10413-106B8	58.58	13.77	3.81
globus pallidus - adult, donor10196	10175-103C4	58.31	3.64	0.00
globus pallidus, adult, donor10252	10161-103A8	71.76	2.93	0.49
globus pallidus, adult, donor10258	10367-105F7	64.35	4.11	0.00
globus pallidus, newborn, donor10223	10364-105F4	27.18	5.86	1.07
granulocyte macrophage progenitor, donor1	12131-128D7	203.11	7.34	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	21.86	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	41.81	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	57.92	9.92	0.64
hIPS +CCl2, biol_rep1	14383-156B9	161.15	66.57	0.92
hIPS +CCl2, biol_rep2	14384-156C1	131.23	55.33	1.37
hIPS +CCl2, biol_rep3	14385-156C2	157.16	61.19	1.29
hIPS, biol_rep1	14380-156B6	102.05	61.80	0.00
hIPS, biol_rep2	14381-156B7	122.77	48.01	1.37
hIPS, biol_rep3	14382-156B8	80.55	12.14	0.00
hairy cell leukemia cell line:Mo	10712-109I1	73.56	11.49	4.60
heart - mitral valve, adult	10205-103F7	41.26	2.39	0.60
heart - pulmonic valve, adult	10206-103F8	50.73	2.88	1.31
heart - tricuspid valve, adult	10207-103F9	47.46	2.50	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	43.26	3.47	0.00
heart, adult, diseased, donor1	10051-101G6	30.23	1.70	0.00
heart, adult, pool1	10016-101C7	50.14	1.38	0.00
heart, fetal, pool1	10046-101G1	54.52	3.70	1.03
hepatic mesenchymal tumor cell line:LI90	10778-110G4	58.93	8.02	1.23
hepatoblastoma cell line:HuH-6	10633-108I3	167.67	36.86	3.57
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	101.88	33.04	1.55
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	109.24	33.86	0.61
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	116.01	33.35	0.71
hepatoma cell line:Li-7	10484-107A7	112.66	23.02	1.56
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	100.20	21.61	0.50
hippocampus - adult, donor10196	10169-103B7	78.55	9.46	0.95
hippocampus, adult, donor10252	10153-102I9	73.27	4.90	0.41
hippocampus, adult, donor10258	10374-105G5	94.61	10.46	1.49
hippocampus, newborn, donor10223	10363-105F3	36.66	7.40	1.76
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	159.91	85.45	3.66
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	78.15	42.02	1.18
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	95.46	50.02	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	74.43	15.22	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	77.72	11.10	0.77
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	61.12	12.53	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	82.91	19.85	0.88
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	69.37	11.20	1.08
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	57.97	18.77	2.50
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	77.90	12.31	0.71
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	73.29	13.66	0.80
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	75.41	18.18	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	67.91	30.20	0.78
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	85.49	39.30	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	84.66	48.87	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	73.12	10.50	1.53
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	71.95	9.59	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	80.96	17.49	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	54.26	7.54	1.51
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	71.39	11.37	1.36
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	62.65	9.71	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	62.22	11.59	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	66.48	11.32	0.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	60.98	9.86	1.20
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	77.04	39.72	1.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	79.31	33.66	2.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	133.11	58.39	1.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	77.46	15.14	1.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	73.48	12.67	0.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	50.84	11.20	0.61
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	71.88	7.76	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	69.74	9.96	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	59.77	14.62	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	62.38	9.97	1.02
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	77.24	10.60	3.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	63.18	11.09	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	81.15	32.36	2.17
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	82.89	44.57	2.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	84.39	40.98	2.44
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	62.65	11.61	0.61
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	325.32	110.61	9.76
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	73.80	19.86	1.65
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	63.49	10.95	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	57.90	9.77	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	49.82	7.83	0.71
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	54.90	14.32	2.39
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	81.26	16.93	0.41
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	55.76	9.70	1.08
immature langerhans cells, donor1	11904-125F5	85.72	23.00	2.42
immature langerhans cells, donor2	11905-125F6	58.62	19.80	1.58
insula, adult, pool1	10039-101F3	77.50	7.95	0.95
keratoacanthoma cell line:HKA-1	10791-110H8	39.02	8.45	0.98
kidney, adult, pool1	10017-101C8	50.66	5.21	0.50
kidney, fetal, pool1	10045-101F9	41.73	4.24	0.85
large cell lung carcinoma cell line:IA-LM	10509-107D5	216.16	49.14	8.66
large cell lung carcinoma cell line:NCI-H460	10839-111E2	42.72	5.25	0.69
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	78.72	18.90	0.73
left atrium, adult, donor1	10079-102A7	44.13	1.63	0.54
left ventricle, adult, donor1	10078-102A6	29.83	0.51	0.00
leiomyoblastoma cell line:G-402	10721-110A1	125.86	14.23	0.82
leiomyoma cell line:10964C	10569-108B2	30.90	2.87	0.72
leiomyoma cell line:15242A	10570-108B3	30.98	6.52	0.54
leiomyoma cell line:15425	10571-108B4	42.98	6.80	1.46
leiomyosarcoma cell line:Hs 5.T	10722-110A2	25.40	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	76.33	30.32	3.14
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	103.89	48.64	5.31
liposarcoma cell line:KMLS-1	10782-110G8	83.10	7.97	2.81
liposarcoma cell line:SW 872	10726-110A6	91.99	13.40	0.73
liver, adult, pool1	10018-101C9	47.65	5.67	0.00
liver, fetal, pool1	10086-102B5	35.75	3.76	0.00
locus coeruleus - adult, donor10196	10182-103D2	46.66	5.54	0.87
locus coeruleus, adult, donor10252	10165-103B3	53.52	7.57	0.37
locus coeruleus, adult, donor10258	10375-105G6	40.35	4.80	1.13
locus coeruleus, newborn, donor10223	10362-105F2	53.42	6.73	1.68
lung adenocarcinoma cell line:A549	10499-107C4	95.08	7.75	0.28
lung adenocarcinoma cell line:PC-14	10408-106B3	99.27	14.48	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	133.40	17.00	0.40
lung, adult, pool1	10019-101D1	36.97	1.06	0.47
lung, fetal, donor1	10068-101I5	95.90	7.99	3.71
lung, right lower lobe, adult, donor1	10075-102A3	49.95	2.29	1.83
lymph node, adult, donor1	10077-102A5	54.44	3.31	0.95
lymphangiectasia cell line:DS-1	10727-110A7	69.70	5.70	1.53
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	61.88	16.30	0.75
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	85.80	45.87	1.70
mature adipocyte, donor1	12231-129F8	83.03	4.88	0.44
mature adipocyte, donor2	12232-129F9	65.79	5.81	0.00
mature adipocyte, donor3	12233-129G1	59.74	3.08	0.00
mature adipocyte, donor4	12234-129G2	72.65	3.69	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	206.57	30.02	2.86
medial frontal gyrus - adult, donor10196	10170-103B8	102.65	15.79	3.38
medial frontal gyrus, adult, donor10252	10150-102I6	70.07	6.62	2.94
medial frontal gyrus, adult, donor10258	10368-105F8	100.71	9.21	1.59
medial frontal gyrus, newborn, donor10223	10352-105E1	89.99	20.04	1.71
medial temporal gyrus - adult, donor10196	10183-103D3	82.86	6.08	2.03
medial temporal gyrus, adult, donor10252	10156-103A3	69.61	5.31	1.49
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	94.39	9.63	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	344.49	43.06	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	63.53	11.49	2.15
medulla oblongata - adult, donor10196	10174-103C3	44.78	1.95	0.65
medulla oblongata, adult, donor10252	10155-103A2	53.87	2.79	0.15
medulla oblongata, adult, pool1	10038-101F2	45.22	4.00	0.08
medulla oblongata, newborn, donor10223	10361-105F1	32.64	5.55	0.35
medulloblastoma cell line:D283 Med	10838-111E1	74.62	17.71	0.66
medulloblastoma cell line:ONS-76	10759-110E3	113.22	22.38	0.24
melanoma cell line:COLO 679	10514-107E1	52.04	20.27	0.57
melanoma cell line:G-361	10465-106H6	55.65	7.60	1.09
meningioma cell line:HKBMM	10691-109F7	47.94	5.25	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	118.96	39.65	1.76
merkel cell carcinoma cell line:MS-1	10844-111E7	107.06	19.18	0.52
mesenchymal precursor cell - adipose, donor1	11747-123G1	78.56	11.35	1.53
mesenchymal precursor cell - adipose, donor2	11748-123G2	55.44	7.82	0.73
mesenchymal precursor cell - adipose, donor3	11749-123G3	47.62	7.87	3.31
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	53.94	4.35	0.70
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	55.84	4.43	1.73
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	39.56	0.00	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	44.28	5.15	0.69
mesenchymal precursor cell - cardiac, donor2	11753-123G7	49.92	6.33	0.23
mesenchymal precursor cell - cardiac, donor3	11754-123G8	65.52	6.10	0.80
mesenchymal precursor cell - cardiac, donor4	11755-123G9	60.77	10.40	0.68
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	81.94	11.81	0.85
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	38.53	2.96	0.99
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	66.97	8.58	1.52
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	48.52	9.43	1.40
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	52.06	6.33	1.43
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	30.55	4.67	1.44
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	40.04	3.41	0.93
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	31.23	6.84	0.91
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	113.70	19.72	2.52
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	62.32	7.62	0.60
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	63.90	9.28	1.58
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	46.76	6.26	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	32.91	5.72	1.43
mesenchymal stem cell line:Hu5/E18	10568-108B1	72.41	16.84	2.11
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	59.82	7.31	1.37
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	49.37	5.12	0.77
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	52.35	4.97	1.83
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	48.37	6.78	0.92
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	41.89	7.53	1.65
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	49.41	5.08	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	46.76	3.54	1.57
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	38.92	5.10	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	46.72	5.77	1.44
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	46.18	5.13	0.45
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	41.10	5.77	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	71.13	3.67	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	43.97	5.37	1.01
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	36.84	4.50	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	43.81	6.44	0.86
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	43.75	16.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	36.15	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	54.89	5.52	0.97
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	39.28	2.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	50.64	8.00	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	40.89	6.54	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	48.20	5.05	0.78
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	44.07	12.59	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	39.74	4.97	1.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	28.60	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	48.62	3.56	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	37.77	6.09	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	44.97	4.43	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	41.39	8.28	2.41
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	19.34	4.30	4.30
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	19.96	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	34.44	3.44	6.89
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	28.52	2.85	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	29.39	3.18	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	20.04	2.95	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	26.81	7.17	1.25
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	28.07	5.35	2.67
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	39.03	4.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	33.38	7.70	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	28.91	4.82	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	48.00	10.39	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	48.22	6.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	62.33	9.54	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	51.58	10.48	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	37.07	8.72	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	38.01	5.07	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	58.26	9.10	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	72.30	9.04	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	52.72	9.88	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	40.28	3.57	1.19
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	39.59	6.49	1.30
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	48.89	2.04	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	51.84	2.32	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	97.80	7.56	0.47
mesothelioma cell line:ACC-MESO-4	10494-107B8	95.45	10.89	5.10
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	29.92	17.09	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	43.26	10.79	0.41
mesothelioma cell line:Mero-25	10850-111F4	54.24	10.21	0.91
mesothelioma cell line:Mero-41	10851-111F5	108.30	10.51	0.00
mesothelioma cell line:Mero-48a	10852-111F6	56.24	13.73	0.66
mesothelioma cell line:Mero-82	10853-111F7	74.11	24.44	1.31
mesothelioma cell line:Mero-83	10854-111F8	61.79	13.62	0.68
mesothelioma cell line:Mero-84	10855-111F9	40.19	4.80	1.26
mesothelioma cell line:Mero-95	10856-111G1	73.29	14.08	2.07
mesothelioma cell line:NCI-H2052	10847-111F1	88.62	19.55	1.16
mesothelioma cell line:NCI-H226	10846-111E9	80.18	19.91	1.81
mesothelioma cell line:NCI-H2452	10848-111F2	88.66	11.79	0.85
mesothelioma cell line:NCI-H28	10845-111E8	61.84	10.69	1.02
mesothelioma cell line:No36	10857-111G2	54.80	15.98	2.28
mesothelioma cell line:ONE58	10858-111G3	43.35	15.72	0.00
migratory langerhans cells, donor1	11901-125F2	37.62	2.30	0.38
migratory langerhans cells, donor2	11902-125F3	33.83	1.34	0.12
migratory langerhans cells, donor3	11903-125F4	47.02	3.05	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	93.37	19.26	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	59.77	6.78	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	136.14	29.95	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	64.51	7.42	4.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	69.48	12.01	0.55
myeloma cell line:PCM6	10474-106I6	76.89	14.03	0.79
myxofibrosarcoma cell line:MFH-ino	10600-108E6	103.99	14.71	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	78.65	13.34	0.59
nasal epithelial cells, donor1, tech_rep1	12226-129F3	49.47	6.13	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	48.17	7.06	0.22
nasal epithelial cells, donor2	12227-129F4	51.89	11.04	1.10
neuroblastoma cell line:CHP-134	10508-107D4	114.11	29.68	0.69
neuroblastoma cell line:NB-1	10539-107G8	106.08	27.50	4.12
neuroblastoma cell line:NBsusSR	10607-108F4	121.89	44.71	1.05
neuroblastoma cell line:NH-12	10555-107I6	88.52	17.89	0.37
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	57.65	8.30	1.66
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	106.11	12.04	1.11
neuroectodermal tumor cell line:TASK1	10774-110F9	74.26	6.24	0.40
neuroepithelioma cell line:SK-N-MC	10728-110A8	179.92	17.80	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	65.48	13.04	1.06
neutrophil PMN, donor1	12133-128D9	163.62	0.00	0.00
neutrophil PMN, donor2	12137-128E4	26.56	13.28	0.00
neutrophil PMN, donor3	12141-128E8	37.88	9.47	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	108.91	20.80	1.01
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	151.30	28.02	1.60
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	53.22	3.53	0.96
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	43.09	5.52	0.79
nucleus accumbens, adult, pool1	10037-101F1	68.34	5.44	0.47
occipital cortex - adult, donor10196	10172-103C1	107.14	8.24	4.12
occipital cortex, adult, donor10252	10163-103B1	70.31	4.03	0.54
occipital cortex, newborn, donor10223	10355-105E4	43.67	8.37	1.82
occipital lobe, adult, donor1	10076-102A4	92.10	8.40	1.84
occipital lobe, fetal, donor1	10073-102A1	133.02	7.72	1.29
occipital pole, adult, pool1	10036-101E9	35.40	2.21	0.47
olfactory region, adult	10195-103E6	73.56	7.45	0.96
optic nerve, donor1	10277-104E7	62.03	2.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	185.33	58.66	5.92
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	96.72	37.37	0.55
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	73.83	16.09	0.68
oral squamous cell carcinoma cell line:SAS	10544-107H4	101.65	21.37	1.96
osteoclastoma cell line:Hs 706.T	10704-109H2	51.74	6.17	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	187.80	34.57	2.80
osteosarcoma cell line:HS-Os-1	10558-107I9	65.53	16.12	2.76
ovary, adult, pool1	10020-101D2	44.81	3.58	0.44
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	108.71	20.53	2.02
pancreas, adult, donor1	10049-101G4	33.86	4.70	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	60.38	13.98	0.84
papillary adenocarcinoma cell line:8505C	10437-106E5	53.32	8.35	0.34
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	78.65	9.27	1.32
paracentral gyrus, adult, pool1	10035-101E8	64.16	6.50	0.55
parietal cortex, adult, donor10258	10373-105G4	63.86	6.61	1.47
parietal lobe - adult, donor10196	10171-103B9	70.54	5.64	1.88
parietal lobe, adult, donor10252	10157-103A4	65.56	6.84	0.86
parietal lobe, adult, pool1	10034-101E7	62.04	6.26	1.67
parietal lobe, fetal, donor1	10072-101I9	118.32	11.64	1.94
parietal lobe, newborn, donor10223	10356-105E5	55.71	14.21	2.99
parotid gland, adult	10199-103F1	61.67	4.93	0.00
penis, adult	10200-103F2	42.97	3.22	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	56.90	5.39	0.74
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	113.79	11.07	1.31
pineal gland - adult, donor10196	10179-103C8	69.02	1.94	0.65
pineal gland, adult, donor10252	10160-103A7	78.17	5.33	1.18
pineal gland, adult, donor10258	10377-105G8	64.59	1.25	0.63
pituitary gland - adult, donor10196	10180-103C9	81.96	10.12	1.01
pituitary gland, adult, donor10252	10162-103A9	115.70	7.82	2.08
pituitary gland, adult, donor10258	10378-105G9	72.36	12.77	2.55
placenta, adult, pool1	10021-101D3	64.29	3.55	0.11
plasma cell leukemia cell line:ARH-77	10840-111E3	75.88	16.02	2.25
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	47.00	5.14	0.93
pons, adult, pool1	10033-101E6	58.18	8.00	0.95
postcentral gyrus, adult, pool1	10032-101E5	51.96	4.97	0.87
promyelocytes/myelocytes PMC, donor1	12132-128D8	190.32	12.55	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	16.52	5.51	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	23.47	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	106.33	13.11	1.89
prostate cancer cell line:PC-3	10439-106E7	210.36	41.75	1.63
prostate, adult, pool1	10022-101D4	53.15	3.63	0.54
putamen, adult, donor10196	10176-103C5	75.54	5.19	0.71
putamen, adult, donor10252	10152-102I8	78.43	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	109.28	20.76	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	60.16	2.42	0.00
putamen, newborn, donor10223	10365-105F5	43.48	8.25	2.25
rectal cancer cell line:TT1TKB	10469-106I1	81.46	27.35	2.91
rectum, fetal, donor1	10067-101I4	150.23	13.91	2.78
renal cell carcinoma cell line:OS-RC-2	10411-106B6	68.90	9.96	1.06
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	30.65	5.38	1.24
retina, adult, pool1	10030-101E3	43.44	1.49	0.50
retinoblastoma cell line:Y79	10475-106I7	83.40	24.68	0.78
rhabdomyosarcoma cell line:KYM-1	10787-110H4	92.21	13.89	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	239.58	49.49	1.69
sacrococcigeal teratoma cell line:HTST	10695-109G2	75.03	11.37	1.52
salivary acinar cells, donor1	11771-123I7	51.47	6.64	1.94
salivary acinar cells, donor2	11772-123I8	39.93	4.68	0.83
salivary acinar cells, donor3	11773-123I9	61.57	11.25	1.99
salivary gland, adult, pool1	10093-102C3	57.20	3.43	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	77.40	14.08	2.36
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	102.15	16.69	2.23
seminal vesicle, adult	10201-103F3	61.90	7.41	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	46.40	9.96	3.40
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	39.76	7.05	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	83.29	15.05	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	72.40	22.30	0.40
signet ring carcinoma cell line:Kato III	10436-106E4	70.41	11.83	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	72.38	18.45	1.68
skeletal muscle - soleus muscle, donor1	10282-104F3	102.14	4.97	0.00
skeletal muscle, adult, pool1	10023-101D5	55.53	1.80	0.36
skeletal muscle, fetal, donor1	10066-101I3	37.19	3.02	0.00
skin, adult, donor1	10074-102A2	27.14	0.00	0.00
skin, fetal, donor1	10065-101I2	89.63	6.94	1.89
small cell cervical cancer cell line:HCSC-1	10800-110I8	127.41	28.68	1.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	54.53	13.55	1.26
small cell lung carcinoma cell line:DMS 144	10841-111E4	153.04	8.10	0.58
small cell lung carcinoma cell line:LK-2	10541-107H1	123.62	45.16	0.82
small cell lung carcinoma cell line:NCI-H82	10842-111E5	81.71	25.25	0.80
small cell lung carcinoma cell line:WA-hT	10562-108A4	122.47	19.39	1.09
small intestine, adult, pool1	10024-101D6	65.81	6.09	0.36
small intestine, fetal, donor1	10064-101I1	60.93	5.41	2.21
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	53.85	23.59	0.51
smooth muscle, adult, pool1	10048-101G3	66.68	1.55	0.52
somatostatinoma cell line:QGP-1	10781-110G7	86.30	12.06	0.54
spinal cord - adult, donor10196	10181-103D1	46.11	3.21	0.46
spinal cord, adult, donor10252	10159-103A6	56.77	3.55	1.58
spinal cord, adult, donor10258	10369-105F9	62.95	2.08	0.00
spinal cord, fetal, donor1	10056-101H2	86.60	7.93	0.00
spinal cord, newborn, donor10223	10359-105E8	64.29	4.13	2.76
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	85.73	11.95	1.19
spleen, adult, pool1	10025-101D7	53.53	4.07	0.55
spleen, fetal, pool1	10044-101F8	41.95	3.97	1.35
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	68.53	14.08	1.97
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	102.91	14.05	0.57
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	63.25	7.34	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	95.78	49.65	1.95
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	97.03	30.28	0.56
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	104.21	14.83	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	89.69	13.12	1.27
stomach, fetal, donor1	10062-101H8	113.21	8.54	1.07
submaxillary gland, adult	10202-103F4	56.40	7.41	0.00
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	46.11	2.49	0.42
substantia nigra, adult, donor10258	10371-105G2	76.04	6.21	0.00
substantia nigra, newborn, donor10223	10358-105E7	33.21	7.77	2.83
synovial sarcoma cell line:HS-SY-II	10441-106E9	169.89	28.89	1.15
temporal lobe, adult, pool1	10031-101E4	40.18	3.14	0.25
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	149.58	6.41	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	76.48	8.35	0.00
tenocyte, donor1	11763-123H8	67.38	5.24	1.40
tenocyte, donor2	11765-123I1	41.58	3.05	0.76
tenocyte, donor3	11768-123I4	50.41	8.15	1.85
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	116.59	41.81	3.91
teratocarcinoma cell line:NCR-G1	10798-110I6	85.55	11.87	2.16
teratocarcinoma cell line:PA-1	10807-111A6	98.10	34.10	1.24
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	61.95	33.39	2.54
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	262.45	153.54	5.29
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	132.73	71.65	4.91
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	119.53	57.98	2.61
testis, adult, pool1	10026-101D8	42.30	3.76	0.32
testis, adult, pool2	10096-102C6	42.40	9.02	0.45
thalamus - adult, donor10196	10168-103B6	60.72	9.94	0.00
thalamus, adult, donor10252	10154-103A1	47.82	4.38	0.63
thalamus, adult, donor10258, tech_rep1	10370-105G1	53.89	6.16	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	39.36	2.96	0.16
thalamus, newborn, donor10223	10366-105F6	46.60	16.68	4.03
throat, adult	10209-103G2	52.43	5.99	0.25
throat, fetal, donor1	10061-101H7	97.81	5.79	0.61
thymic carcinoma cell line:Ty-82	10803-111A2	94.40	22.46	2.78
thymus, adult, pool1	10027-101D9	91.26	7.65	0.50
thymus, fetal, pool1	10043-101F7	76.68	8.73	1.97
thyroid carcinoma cell line:KHM-5M	10776-110G2	94.27	23.80	0.27
thyroid carcinoma cell line:TCO-1	10783-110G9	71.38	12.57	0.84
thyroid, adult, pool1	10028-101E1	58.41	4.85	0.19
thyroid, fetal, donor1	10060-101H6	102.04	6.59	1.58
tongue epidermis (fungiform papillae), donor1	10288-104F9	55.43	6.16	0.00
tongue, adult	10203-103F5	55.59	9.77	0.23
tongue, fetal, donor1	10059-101H5	90.25	5.52	1.18
tonsil, adult, pool1	10047-101G2	56.10	7.11	1.00
trachea, adult, pool1	10029-101E2	50.06	5.15	0.41
trachea, fetal, donor1	10058-101H4	53.86	7.69	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	69.08	15.23	1.06
transitional-cell carcinoma cell line:5637	10418-106C4	104.46	28.98	1.11
transitional-cell carcinoma cell line:JMSU1	10492-107B6	99.50	15.36	1.72
tridermal teratoma cell line:HGRT	10694-109G1	123.66	7.61	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	77.62	8.13	1.27
umbilical cord, fetal, donor1	10057-101H3	54.25	0.00	4.17
uterus, adult, pool1	10100-102D1	65.35	2.90	1.88
uterus, fetal, donor1	10055-101H1	104.43	10.24	1.02
vagina, adult	10204-103F6	37.48	1.94	0.00
vein, adult	10191-103E2	41.21	4.38	0.88
xeroderma pigentosum b cell line:XPL 17	10563-108A5	52.07	6.94	0.53